IBUPROFEN IN THE TREATMENT OF INFLAMMATORY DISEASES OF JOINTS IN CHILDREN


Cite item

Full Text

Abstract

Treatment of acute and chronic inflammatory disease of joints in children is a challenge for the pediatrician and rheumatologist. Traditionally, therapeutic algorithms of treatment of arthritis in children include non-steroidal anti-inflammatory drugs, which have a unique combination of anti-inflammatory, analgesic and antipyretic action. The article summarizes the available results of use of ibuprofen in juvenile arthritis in children. Application of ibuprofen is characterized by good tolerability and rare development of adverse events. Permit for use of ibuprofen from the age of 3 months and older allows to consider it as drug of choice for initial therapy of inflammatory diseases of joints in children.

References

  1. Баранов А.А., Насонов Е.Л., Алексеева Е.И. и др. Состояние специализированной ревматологической помощи детям и взрослым в Российской Федерации // Вопросы современной педиатрии 2007. № 1. С. 6-8.
  2. Cassidy JT, Petty RE, Laxer RM, et al. Textbook of Pediatric Rheumatology 5th ed. Philadelphia 2005.
  3. Rainsford KD. Anti-inflammatory drugs in the 21st century // Subcell Biochem 2007;42:3-27.
  4. Насонов Е.Л. Нестероидные противовоспалительные препараты (Перспективы применения в медицине). М., 2000. 142 с.
  5. Jacqz-Aigrain E, Anderson BJ. Pain control: non-steroidal anti-inflammatory agents. Semin Fetal Neonatal Med 2006;11(4):251-59.
  6. Neubert A, Verhamme K, Murray ML, et al. The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res 2010;62(3):243-48.
  7. Fuhlbrigge RC, Chaiban R. The immune system, the skin, and childhood rheumatic disease. Curr Rheumatol Rep 2011;13(2):103-9.
  8. Dannecker GE, Quartier P. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments. Horm Res 2009;72(1):4-12.
  9. Martini A, Lovell DJ. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 2010;69(7):1260-63.
  10. Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract 2003;135:9-12.
  11. van den Anker JN. Use of ibuprofen in paediatric populations. J R Soc Med 2007;100:18-22.
  12. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 2009;17(6):275-342.
  13. Giacovazzo M, Paoluzi P, Pallone F, et al. Double-blind clinical experiences with a new anti-rheumatic drug: ibuprofen. Minerva Med 1973;64(48):2558-60.
  14. Steans A, Manners PJ, Robinson IG. A multicentre, long-term evaluation of the safety and efficacy of ibuprofen syrup in children with juvenile chronic arthritis. Br J Clin Pract 1990;44(5):172-75.
  15. Giannini EH, Brewer EJ, Miller ML, et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr 1990;117(4):645-52.
  16. Goldenstein-Schainberg C, Yoshinari NH. Drug treatment in juvenile chronic arthritis. Rev Hosp Clin Fac Med Sao Paulo 1997;52(2):90-5.
  17. Hollingworth P. The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases. Br J Rheumatol 1993;32(1):73-7.
  18. Flatø B, Vinje O, Førre O. Toxicity of antirheumatic and anti-inflammatory drugs in children. Clin Rheumatol 1998;17(6):505-10.
  19. Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007;14(5):477-84.
  20. Алексеева Е.И., Литвицкий П.Ф. Ювенильный ревматоидный артрит. М., 2007. 368 с.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies